A team at Kobe University has created a game-changing resource for autism research: 63 mouse embryonic stem cell lines, each ...

RNA gene scissors (CRISPR-Cas13) are gaining significant attention as a next-generation gene therapy with fewer side effects.

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

Turning a $10,000 investment into $1 million represents a financial dream for many — a 100x return that would require an ...

Crispr Therapeutics' current revenue from CASGEVY is limited by high costs, profit-sharing, and logistical hurdles. Click ...

Cells are constantly subjected to DNA damage from a range of internal and environmental sources. It is estimated that cells ...

A newly discovered bacterial defense protein named Cat1 reveals an extraordinary method of viral neutralization. All living ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.11, a high estimate of $68.00, ...

Shares of CRISPR Therapeutics CRSP have risen 14% over the past month, likely driven by encouraging results from the first candidates in its in vivo pipeline. CRSP’s Positive In Vivo Therapy Data Last ...